Announcement of Amendment to Guidance for Pediatric Pharmacokinetic Studies

According to the pharmaceutical reforms and many amendments to clinical trials-related regulations for pharmaceuticals in recent years, to promote the pediatric drug development and to raise the standards for clinical trials in Taiwan, Ministry of Health and Welfare issued an announcement of amendment to Guidance for Pediatric Pharmacokinetic Studies.
 
【Issue date: 2021-03-23】 
【Announcement: MOHW No. 1101401255】 
 
Reference: https://www.fda.gov.tw/TC/siteListContent.aspx?sid=9354&id=36113